Related Information
This kit demonstrates the compact storage size and portability of Novo Nordisk products like Novoeight®, and helps you show patients how quick it is to reconstitute a dose. Patients may practice mixing a placebo dose to become familiar with the process before leaving your office. Please see full Prescribing Information for complete Instructions for Use for Novoeight®.
Novoeight® (antihemophilic factor, recombinant) is indicated for use in adults and children with hemophilia A for on-demand treatment and control of bleeding episodes, perioperative management, and routine prophylaxis to reduce the frequency of bleeding episodes.